Key Takeaways:
5-Year Pilot Program:Â Starting as early as 2026, Medicaid and Medicare may opt to cover GLP-1 weight-loss drugs like Ozempic and Wegovy, expanding access beyond diabetes-related conditions.
Big Costs, Big Market:Â The drugs run up to $7,000 per year, with analysts...
Key Takeaways:
Routine Update, Loud Reaction: The Smithsonian removed a temporary Trump impeachment label as part of a larger exhibit update—prompting...
